News
Orion and Abilita Therapeutics to develop innovative antibody therapeutics
Orion Corporation and Abilita Therapeutics have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas...
Roche’s Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause...
The European Medicines Agency has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’...
Conduit Pharmaceuticals partners with Sarborg to leverage AI and cybernetics to optimize drug development
Conduit Pharmaceuticals has entered into an agreement with Sarborg to leverage an advanced artificial intelligence (AI) and cybernetics platform to evaluate key deliverables across...
